The Effective Control of Hyperuricemia in Cancer Patients: A New Recombinant Conjugated Variant of Urate Oxidase

OBJECTIVE: Management of hyperuricemia is crucial to controlling tumor lysis syndrome (TLS) during cancer therapy. Urate oxidase (UOX) that catalyzes the enzymatic oxidation of uric acid into allantoin, is effective in lowering plasma uric acid levels and controlling hyperuricemia. Recently, we deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Najjari, Abbas, Shahbazmohammadi, Hamid, Omidinia, Eskandar, Movafagh, Abolfazl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190373/
https://www.ncbi.nlm.nih.gov/pubmed/33639683
http://dx.doi.org/10.31557/APJCP.2021.22.2.627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190373/
https://www.ncbi.nlm.nih.gov/pubmed/33639683
http://dx.doi.org/10.31557/APJCP.2021.22.2.627

Ejemplares similares